Hemodynamic Monitoring System Market Set for Rapid Growth and Trend by 2027


The growth of US hemodynamic monitoring system is estimated due to the factors such as increasing product developments and approvals, rising cardiovascular disease prevalence, and growing geriatric population. On the other hand, the market is projected to experience slow growth due to risks associated with invasive hemodynamic monitoring systems.

Advancements in medical technology and innovations, as well as increase in R&D spending by manufacturers, have resulted in the launch of various medical devices, including hemodynamic monitoring systems. At present, the hemodynamic monitoring systems are used to guide physicians to design the therapies or treatments at the time of circulatory instability for the patients living with cardiovascular diseases.



Top Dominating Key Players:
  1.       General Electric Company
  2.        LIDCO
  3.        Pulsion Medical Systems SE (Getinge)
  4.        Koninklijke Philips N.V
  5.        ICU Medical, Inc.
  6.        Cheetah Medical (Baxter International)
  7.        Deltex Medical
  8.        Schwarzer Cardiotek
  9.        Edwards Lifesciences Corporation
  10.     Osypka Medical GmBH
In the US, various players are operating in the hemodynamic monitoring system market; they are involved in the product development activities. For instance, in February 2018, Getinge AB has received Section 510(k) clearance from FDA for its PulsioFlex Monitoring System and PiCCO Module. It is a modular platform integrated with intelligent visualization for advanced hemodynamic patient monitoring. The PulsioFlex Monitoring System is ideal for use in clinical settings such as operating rooms (ORs), emergency rooms (ERs), and intensive care units (ICUs).

Similarly, various international players have launched more such hemodynamic monitoring systems. For instance, in March 2018, Canon Medical Systems Corporation (Japan) acquired a Netherlands-based company named Fysicon B.V. In September 2017, Fysicon B.V. received FDA’s Section 510(k) clearance for its QMAPP Hemodynamic Monitoring systems designed for monitoring the cardiac conditions of patients in cardiac catheterization labs. Further, in April 2016, Siemens Healthineers (Siemens AG) launched its revamped version of Sensis Vibe.

The system was launched at the American College of Cardiology’s 65th Annual Scientific Session (ACC.16), held during April 2–4, 2016, in Chicago, Illinois, US. The system enables catheterization lab professionals to manage data proficiently, and it also assists in streaming down the documentation and reporting in the interventional treatments.

Purchase for Report @ https://bit.ly/2wNe4ax

Key Benefits:

  • This report provides a detailed study of market trends and forecast from 2019 to 2025, which assist to identify the prevailing market opportunities.
  • In-depth coverage of the global market that includes drivers, restraints, and opportunities, helps professionals to understand the market behavior in a better way.
  •  Detailed study of the strategies of key leaders, partnerships, and acquisitions in the market is provided.

Comments

Popular posts from this blog

Immunochemistry Equipment Market to Reflect a Holistic Expansion During 2019 to 2027

Biopharmaceutical Contract Manufacturing Market to Witness an Outstanding Growth by 2027

Patient Registry Software Market Set for Rapid Growth and Trend by 2027